Carregant...

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom

BACKGROUND: Overactive bladder (OAB) is highly prevalent and is associated with considerable morbidity and reduced health-related quality of life. β(3)-adrenergic receptor (β(3)-AR) stimulation is a novel alternative to antimuscarinic therapy for OAB. OBJECTIVE: The objective of this analysis was to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Drug Investig
Autors principals: Aballéa, Samuel, Maman, Khaled, Thokagevistk, Katia, Nazir, Jameel, Odeyemi, Isaac A. O., Hakimi, Zalmai, Garnham, Andy, Toumi, Mondher
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300413/
https://ncbi.nlm.nih.gov/pubmed/25491433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-014-0240-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!